Skip to main content

Table 1 Percentage of patients with Bullous pemphigoid and diabetes mellitus according to the type of gliptins

From: The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study

 

n

% patients with BP

% patients with type 2 diabetes

Patients with diabetes

76

67.3%

100%

Treatment with DPP-4is

52

46%

68%

Vildagliptin

11

9.7%

14.4%

Vildagliptin-Metformin

34

30.1%

44.73%

Linagliptin

3

2.7%

3.9%

Sitagliptin

1

0.9%

1.3%

Sitagliptin-Metformin

2

1.8%

2.6%

Alogliptin-Metformin

1

0.9%

1.3%

Saxagliptin

1

0.9%

13%

  1. BP Bullous pemphigoid, DPP-4is Dipeptidyl-peptidase 4 inhibitors
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us